HempMeds Brasil, a subsidiary of Medical Marijuana, Inc. announced that April 2021 broke records for the best revenue month in company history.
“Our HempMeds Brasil operations have seen a consistent increase over the years,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “We aim to reach as many consumers in need as possible and last month’s achievements prove that we are continuing to expand our reach to our target audiences.”
The company did not release exact revenue figures, but explained that it would be scaling its Brazil operations to match demand, refreshing its consumer-facing website and increasing the size of its Brazil facilities in response to April’s revenue.
“In the coming months, to support our continued growth, we intend to partner with the largest higher education institution in Brazil to educate medical professionals on the potential benefits of cannabidiol (CBD) and are moving forward in securing partnerships with well-respected professional and Olympic athletes,” said HempMeds® Brasil Managing Director Matheus Patelli. “My team has successfully been able to show Brazilian citizens that our products are of the highest quality and trustworthy, just like the people who work at the Company.”
